Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Professor Peter Piot Joins the Board of Biocon Biologics Limited as an Independent Director

Posted On: 2021-01-21 01:36:22 (Time Zone: Arizona, USA)


Biocon Biologics Ltd., a fully integrated 'pure play' biosimilars company and a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), announced today that it has inducted Professor Peter Piot to its Board as an Independent Director. Professor Piot, MD, PhD is the Director of the London School of Hygiene & Tropical Medicine and the Handa Professor of Global Health.

Ms Kiran Mazumdar-Shaw, Executive Chairperson, Biocon, said: "I welcome Professor Peter Piot to the Biocon Biologics board. He brings years of scientific expertise, long experience in public health interventions and policy framing on major health issues. His thought leadership and invaluable experience in global healthcare will greatly guide our actions in building Biocon Biologics into an innovative global leader in biosimilars committed to delivering affordable access to life saving Biologics."

On his decision to join the Biocon Biologics board, Professor Peter Piot said: "I am delighted to join dynamic Biocon Biologics and its vital mission of bringing the products of innovation to those who can benefit from them. The world over governments are challenged to contain the spiralling healthcare costs and companies like Biocon Biologics are committed to pursue the path of innovation that enables affordable access to patients globally and in turn helps healthcare systems lower their spends. With several exciting biosimilar molecules in its pipeline, I believe Biocon Biologics has the potential to be truly disruptive in addressing a global need for high quality, affordable biosimilar therapies to treat chronic diseases like diabetes and cancer and save many lives."

Professor Piot has been appointed to the board of Biocon Biologics Limited for a period of three years starting January 21, 2021.

Professor Peter Piot was initially trained in infectious diseases and medical microbiology, with original contributions in epidemiology, bacteriology, virology, and public health policy interventions mostly in low- and middle-income countries. He is connected to extensive science networks across all continents.

Professor Piot was part of the team that isolated the Ebola virus in Zaire in 1976. He also led pioneering research on HIV/AIDS, women's health and infectious diseases, mostly in Africa. He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, bringing AIDS to the forefront of the world's agenda, and ensuring access to life saving antiretroviral medicines.

He has a broad and long term understanding of strategy development and implementation; leadership of both a large inter-governmental organization and of academic institutions; and policy development in health, science, biotechnology, and international development. He has authored over 600 scientific publications and 16 books, including his memoir "No Time to Lose". He is the recipient of the Calderone Prize, the Hideyo Noguchi Africa Prize for Medical Research, the Prince Mahidol Award for Public Health, the Canada Gairdner Global Health Award and the Robert Koch Gold Medal, and was a 2014 Time Person of the Year "The Ebola Fighters".

Shares of BIOCON LTD. was last trading in BSE at Rs.449.7 as compared to the previous close of Rs. 451.7. The total number of shares traded during the day was 81227 in over 2497 trades.

The stock hit an intraday high of Rs. 453.05 and intraday low of 448.35. The net turnover during the day was Rs. 36600407.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Glenmark signs on Rohit Sharma as brand ambassador of Candid Powder

Waa Solar Ltd Board aprovies 1:1 Bonus Issue

Coal India Ltd board approves 2nd interim dividend of Rs. 5

WeP Solutions Limited fixes March 12, 2021 as record date for rights issue

HGS Digital Partners with Automation Anywhere to Deliver End-to-End Process Automation Solutions in the Customer Experience Industry

PNB Housing Finance and YES BANK enter into strategic co-lending partnership

PVR Cinemas unveil Mysuru's Biggest 6-Screen multiplex in Forum Centre City Mall

Shilpa Medicare Ltd receives US FDA tentative approval for Apremilast Tablets, 10 Mg, 20 Mg, And 30 Mg

RITES Ltd Board to consider Second Interim Dividend on Mar 12, 2021

Mexico's GigNet selects Tejas Networks for its Metro Optical network in Cancun

Dilip Buildcon Ltd receives LOA from NHAI for 2 projects under Bangalore Chennai Expressway

BCPL Railway Infra secures path-breaking order in the railway electrification segment

Indian Bank to consider raising funds of Rs. 4000 crore through equity

Economic Times awards The Byke Hospitality Ltd. for Affordable Luxury Resort Stay

IndiGo strengthens regional connectivity, announces Bareilly as its 67th destination

TATA Tea Gold celebrates this Women's day by launching 'Dil Ki Suno' stories of today's women

Dabur launches 'Vatika Select' premium range of shampoos

Isgec to Set Up World's Largest Waste Heat Recovery Boilers

CRISIL updates on ratings of Brookfield India Real Estate Trust

Max Healthcare Institute Limited opens QIP, fixes floor price as Rs. 190.40

Engineers India Ltd board to consider interim dividend for FY21

Wipro to acquire Capco, a global management and technology consultancy to banking and financial services industry, for $ 1.45 billion

AI Champdany Industries Ltd announces temporary suspension of work at Unit - Wellington Jute Mill - Rishra

Honeywell Automation India limited names Dr. Ganesh Natarajan as Chairman

Laurus Labs Ltd's promoters have sold shares to release pledge on shares

Jay Shree Tea & Industries Ltd to sell Tea Estates at Valparai

TCS a Leader in Digital Finance and Accounting Business Process Services: IDC MarketScape

Unichem Laboratories Ltd receives ANDA approval for Guanfacine Tablets

NBCC India Limited executes MoU with Rashtriya Ispat Nigam Ltd

Dilip Buildcon Ltd receives LOA from Mahanadi Coalfield Ltd for mining project in Odisha

Torrent Power Ltd updates on power distribution tender

Ind-Ra upgrades long-term issuer rating of Prism Johnson Ltd

Hind Rectifiers Limited secures order of Rs. 72.02 crores

Reliance Power Limited and JERA JV achieves financial closure for power project in Bangladesh

Smruthi Organics Ltd fixes March 12, 2021 as record date for bonus issue

Thomas Cook India & SOTC partner with Air Asia & Sterling Holiday Resorts to leverage travel demand

Vivimed's FDF facility in Jeedimetla Obtained Ukraine GMP Approval (renewal)

Sangam Renewables Limited arm commissions 16MW solar project

ABB India joins hands with Lila Poonawalla Foundation to build future women leaders in technology

Wardwizard Innovations & Mobility Limited fixes record date for stock split

Ashoka Buildcon enters into SPA with IIF for acquiring 49% stake in SPV

TCS to Help VodafoneZiggo Accelerate its B2B Fixed Fiber Network Rollout Using AI

RailTel Corporation of India Ltd receives order from BSNL

Finolex Cables strengthens its FMEG portfolio!

IEX electricity market sees splendid 50% YoY volume growth in February 2021

ACUITE A- long-term rating assigned to Superhouse Limited

Shilpa Medicare Limited enters into Gynecology Segment by launching its First Women Intimate Cleansing Spray in India under the Brand Name 'SwatchShil'

Satin Creditcare Network Ltd re-certified as Great Place to Work™ second year in a row

Aleor Dermaceuticals receives USFDA Final Approval for Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation)

eBay in India joins hands with 75 years old Kerala Ayurveda, aims at introducing authentic Ayurveda for the US market



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020